Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)
<p>Abstract</p> <p>Background</p> <p>Secondary treatment of arteriosclerosis may be applicable for the primary prevention of atherosclerosis in diabetic patients. This prospective, 2-year follow-up study was designed to determine the efficacy and safety of antiplatelet...
Main Authors: | Kawamori Ryuzo, Kim Young-Seol, Yamasaki Yoshimitsu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-08-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/5/1/16 |
Similar Items
-
Antiplatelet Resistance in Patients with Atherosclerosis
by: Locāne Sintija, et al.
Published: (2019-08-01) -
Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial
by: Jiachuan Xiong, et al.
Published: (2021-01-01) -
Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study
by: Teruo Kimura, et al.
Published: (2016-10-01) -
The Prevention and Treatment of Atherosclerosis
Published: (2022) -
The Role of Coping in Preventing Atherosclerosis
by: Kristensen, Judit, et al.
Published: (2019)